Aerssens J - Search Results

1

Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations.

Piotrovsky V, Van Peer A, Van Osselaer N, Armstrong M, Aerssens J. Piotrovsky V, et al. Among authors: aerssens j. J Clin Pharmacol. 2003 May;43(5):514-23. J Clin Pharmacol. 2003. PMID: 12751272

2

The human genome: an introduction.

Aerssens J, Armstrong M, Gilissen R, Cohen N. Aerssens J, et al. Oncologist. 2001;6(1):100-9. Oncologist. 2001. PMID: 11161233 Free article. Review. No abstract available.

3

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J. Paulussen AD, et al. Among authors: aerssens j. J Mol Med (Berl). 2004 Mar;82(3):182-8. doi: 10.1007/s00109-003-0522-z. Epub 2004 Feb 4. J Mol Med (Berl). 2004. PMID: 14760488

4

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Aerssens J, Camilleri M, Talloen W, Thielemans L, Göhlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Aerssens J, et al. Clin Gastroenterol Hepatol. 2008 Feb;6(2):194-205. doi: 10.1016/j.cgh.2007.11.012. Clin Gastroenterol Hepatol. 2008. PMID: 18237869 Free PMC article.

5

A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.

Paulussen A, Raes A, Matthijs G, Snyders DJ, Cohen N, Aerssens J. Paulussen A, et al. Among authors: aerssens j. J Biol Chem. 2002 Dec 13;277(50):48610-6. doi: 10.1074/jbc.M206569200. Epub 2002 Sep 26. J Biol Chem. 2002. PMID: 12354768 Free article.

6

Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.

Paulussen A, Matthijs G, Gewillig M, Verhasselt P, Cohen N, Aerssens J. Paulussen A, et al. Among authors: aerssens j. Genet Test. 2003 Spring;7(1):57-61. doi: 10.1089/109065703321560958. Genet Test. 2003. PMID: 12820704

7

Pharmacogenomics and acquired long QT syndrome.

Aerssens J, Paulussen AD. Aerssens J, et al. Pharmacogenomics. 2005 Apr;6(3):259-70. doi: 10.1517/14622416.6.3.259. Pharmacogenomics. 2005. PMID: 16013957 Review.

8

A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes.

Saenen JB, Paulussen AD, Jongbloed RJ, Marcelis CL, Gilissen RA, Aerssens J, Snyders DJ, Raes AL. Saenen JB, et al. Among authors: aerssens j. J Mol Cell Cardiol. 2007 Jul;43(1):63-72. doi: 10.1016/j.yjmcc.2007.04.012. Epub 2007 May 4. J Mol Cell Cardiol. 2007. PMID: 17531263

9

Risk factors for drug-induced long-QT syndrome.

Paulussen AD, Aerssens J. Paulussen AD, et al. Among authors: aerssens j. Neth Heart J. 2005 Feb;13(2):47-56. Neth Heart J. 2005. PMID: 25696450 Free PMC article. Review.

10

HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.

Paulussen AD, Raes A, Jongbloed RJ, Gilissen RA, Wilde AA, Snyders DJ, Smeets HJ, Aerssens J. Paulussen AD, et al. Among authors: aerssens j. Cardiovasc Res. 2005 Aug 15;67(3):467-75. doi: 10.1016/j.cardiores.2005.05.017. Cardiovasc Res. 2005. PMID: 15958262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters